Cited by 337Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Dunaif, Andrea, Wu, Xinqi, Lee, Anna, Diamanti-Kandarakis, Evanthia·2001·American Journal of Physiology-Endocrinology and Metabolism

DOI 10.1152/ajpendo.2001.281.2.e392

Open this paper in CoChat — free account

Abstract

Women with polycystic ovary syndrome (PCOS) are insulin resistant secondary to a postbinding defect in insulin signaling. Sequential euglycemic glucose clamp studies at 40 and 400 mU · m −2 · min −1 insulin doses with serial skeletal muscle biopsies were performed in PCOS and age-, weight-, and ethnicity-matched control women. Steady-state insulin levels did not differ, but insulin-mediated glucose disposal was significantly decreased in PCOS women ( P < 0.05). Insulin receptor substrate (IRS)-1-associated phosphatidylinositol 3-kinase (PI 3K) activity was significantly decreased in PCOS ( n = 12) compared with control skeletal muscle ( n = 8; P < 0.05). There was no significant difference in the abundance of IR, IRS-1, or the p85 regulatory subunit of PI 3K in PCOS ( n = 14) compared with control ( n = 12) muscle. The abundance of IRS-2 was significantly increased ( P < 0.05) in PCOS skeletal muscle, suggesting a compensatory change. We conclude that there is a physiologically relevant defect in insulin receptor signaling in PCOS that is independent of obesity and type 2 diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.2001.281.2.e392

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Self-citation
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Self-citation
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
Phosphatidylinositol 3-Kinase Activation Is Required for Insulin Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation
Cheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 911

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 10

Book CB, 1999, J Clin Endocrinol Metab, 84, 3110
10.1128/MCB.14.7.4902 · DOI
Ciaraldi TP, 1992, J Clin Endocrinol Metab, 75, 577
DeFronzo RA., 1997, Diabetes Rev, 5, 177
Dunaif A., 1997, Endocr Rev, 18, 774
Dunaif A, 1996, J Clin Endocrinol Metab, 81, 3299
Evans WJ, 1982, Med Sci Sports Exerc, 14, 101
Knochenhauser ES, 1998, J Clin Endocrinol Metab, 83, 3078
Legro RS, 1999, J Clin Endocrinol Metab, 84, 165
White MF., 1998, Recent Prog Horm Res, 53, 119

Sorted by citations

Items 101–200 of 337

High prevalence of metabolic syndrome among young women with premature coronary artery disease
Turhan, H., Yaşar, A. S., Başar, N., Biçer, A., Erbay, A. R., & Yetkın, E. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200502000-00007 · Cited by 57
Negative association of acetate with visceral adipose tissue and insulin levels
Layden, B. T., Yalamanchi, Wolever, Dunaif, & Löwe (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s29244 · Cited by 60
Diagnostic Criteria for Polycystic Ovarian Syndrome
Broekmans, F. J., & Fauser, B. C. J. M. (2006) · Endocrine · doi:10.1385/endo:30:1:3 · Cited by 56
Insulin and Messenger Ribonucleic Acid Expression of Insulin Receptor Isoforms in Ovarian Follicles from Nonhirsute Ovulatory Women and Polycystic Ovary Syndrome Patients
Phy, J. L., Conover, C. A., Abbott, D. H., Zschunke, M. A., Walker, D. L., Session, D. R., Tummon, I. S., Thornhill, A. R., Lesnick, T. G., & Dumesic, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031888 · Cited by 56
Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
Liu, S., Mo, M., Xiao, S., Li, L., Hu, X., Hong, L., Wang, L., Lian, R., Huang, C., Zeng, Y., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.575337 · Cited by 59
Intractable Early Childhood Obesity as the Initial Sign of Insulin Resistant Hyperinsulinism and Precursor of Polycystic Ovary Syndrome
Littlejohn, E. E., Weiss, R. E., Deplewski, D., Edidin, D. V., & Rosenfield, R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.1.41 · Cited by 55
Developmental Programming: Differential Effects of Prenatal Testosterone Excess on Insulin Target Tissues
Nada, S. E., Thompson, R. C., & Padmanabhan, V. (2010) · Endocrinology · doi:10.1210/en.2010-0666 · Cited by 54
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Self-citation
Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo
Rajkhowa, M., Brett, S., Cuthbertson, D. J., Lipina, C., Ruiz‐Alcaraz, A. J., Thomas, G. E., Logie, L., Petrie, J. R., & Sutherland, C. D. (2008) · Biochemical Journal · doi:10.1042/bj20082176 · Cited by 56
The role of the endogenous opioid system in polycystic ovary syndrome
Eyvazzadeh, A. D., Pennington, K. P., Pop‐Busui, R., Sowers, M., Zubieta, J., & Smith, Y. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.05.012 · Cited by 54
A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome
Lee, E.-J., Oh, B., Lee, J., Kimm, K., Lee, S., & Baek, K. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.026 · Cited by 54
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
Corbould, A. M., & Dunaif, A. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.021 · Cited by 52
Self-citation
Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
Yen, H.-W. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah066 · Cited by 52
Obesity and Polycystic Ovary Syndrome
Kim, J. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24035 · Cited by 53
Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling
Azziz, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021131 · Cited by 52
Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
Yau, T., Ng, N. Y. H., Cheung, L., & Ronald, C. W. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj176308 · Cited by 49
Fertility in Polycystic Ovary Syndrome
Patel, S. M., & Nestler, J. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.005 · Cited by 48
Prenatal androgen excess programs metabolic derangements in pubertal female rats
Yan, X., Dai, X., Wang, J., Zhao, N., Cui, Y., & Liu, J. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0577 · Cited by 46
Insulin resistance and fertility in polycystic ovary syndrome.
Fica, S. V., Albu, A. I., Constantin, M., & Dobri, G. A. (2008) · PubMed Central · Cited by 46
Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS
Halama, A., Aye, M. M., Dargham, S. R., Kuliński, M., Suhre, K., & Atkin, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00116 · Cited by 45
Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
Karakas, S. E., Kim, K., & Dulęba, A. J. (2010) · Diabetes Care · doi:10.2337/dc09-1525 · Cited by 51
Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole‐Induced Experimental Polycystic Ovary Syndrome
Zhou, Y., Lan, H., Dong, Z., Li, W., Qian, B., Zeng, Z., He, W., & Song, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5558599 · Cited by 44
Androgens and Insulin – Two Key Players in Polycystic Ovary Syndrome
Schüring, A. N., Schulte, N., Sonntag, B., & Kiesel, L. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111465 · Cited by 43
Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol.
Ghowsi, M., Khazali, H., & Sisakhtnezhad, S. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.24801.6167 · Cited by 43
Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome
Alexandraki, K., Protogerou, A. D., Papaioannou, T., Piperi, C., Mastorakos, G. P., Lekakis, J. P., Panidis, D., & Diamanti‐Kandarakis, E. (2006) · HORMONES · doi:10.14310/horm.2002.11176 · Cited by 43
Self-citation
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study
Dalamaga, Μ., Papadavid, E., Basios, G., Vaggopoulos, V., Rigopoulos, D., Kassanos, D., & Trakakis, E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.014 · Cited by 42
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome
Shaaban, Z., Khoradmehr, A., Amiri‐Yekta, A., Nowzari, F., Shirazi, M. R. J., & Tamadon, A. (2021) · Genetics Research · doi:10.1155/2021/7781823 · Cited by 46
Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study
Reyes-Muñoz, E., Ortega-González, C., Martínez-Cruz, N., Arce-Sánchez, L., Estrada‐Gutiérrez, G., Morán, C., Sánchez-Serrano, A. P., Higareda-Sánchez, R., & la Jara-Díaz, J. F. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012107 · Cited by 41
[Genetic aspects of polycystic ovary syndrome].
Jakubowski, L. (2005) · PubMed · Cited by 40
Genetic Markers of Polycystic Ovary Syndrome: Emphasis on Insulin Resistance
Shaikh, N. J., Dadachanji, R., & Mukherjee, S. (2014) · International Journal of Medical Genetics · doi:10.1155/2014/478972 · Cited by 44
Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep1
Lu, C., Cardoso, R. C., Puttabyatappa, M., & Padmanabhan, V. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.136283 · Cited by 40
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome
Dabadghao, P., Roberts, B. J., Wang, J. J., Davies, M. J., & Norman, R. J. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01273.x · Cited by 39
Electrical vs Manual Acupuncture Stimulation in a Rat Model of Polycystic Ovary Syndrome: Different Effects on Muscle and Fat Tissue Insulin Signaling
Johansson, J., Mannerås-Holm, L., Shao, R., Olsson, A., Lönn, M., Billig, H., & Stener‐Victorin, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054357 · Cited by 39
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38
Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 38
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
Rold??n, B., n, J. L. S. M., & Escobar-Morreale, H. F. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00004 · Cited by 39
Role of changes in dietary habits in polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60927-3 · Cited by 39
Polycyclic aromatic hydrocarbons are associated with insulin receptor substrate 2 methylation in adipose tissues of Korean women
Kim, Y. H., Lee, Y. S., Lee, D. H., & Kim, D. S. (2016) · Environmental Research · doi:10.1016/j.envres.2016.05.043 · Cited by 38
Polycystic Ovary Syndrome: Novel and Hub lncRNAs in the Insulin Resistance-Associated lncRNA–mRNA Network
Zhao, J., Huang, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00772 · Cited by 37
Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Glintborg, D., Højlund, K., Andersen, N. R., Hansen, B. F., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0760 · Cited by 37
Correlation between Expression of Glucose Transporters in Granulosa Cells and Oocyte Quality in Women with Polycystic Ovary Syndrome
Kim, E., Seok, H. H., Lee, S.-Y., Lee, D. R., Moon, J., Yoon, T. K., Lee, W. S., & Lee, K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.1.40 · Cited by 36
Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis
Ruan, Y., Ma, J., & Xie, X. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0387 · Cited by 36
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35
Prenatal Steroids and Metabolic Dysfunction: Lessons from Sheep
Cardoso, R. C., & Padmanabhan, V. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115154 · Cited by 34
Stress in Women
Diamanti‐Kandarakis, E., & Economou, F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.006 · Cited by 35
Self-citation
Insulin resistance and the polycystic ovary syndrome
Hao, G. (2005) · Journal of reproductive medicine · Cited by 33
Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea
Lam, J. C. M., Tan, K. C. B., Lai, A. Y. K., Lam, D. C.-L., & Ip, M. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.07.015 · Cited by 31
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 32
Self-citation
Polymorphisms of the peroxisome proliferator–activated receptor-γ and its coactivator-1α genes in Chinese women with polycystic ovary syndrome
Wang, Y., Wu, X., Cao, Y., Yi, L., Fan, H., & Chen, J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.047 · Cited by 31
Self-citation
The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat’s offspring in adulthood
Noroozzadeh, M., Tehrani, F. R., Sedaghat, K., Godini, A., & Azizi, F. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0198-y · Cited by 29
Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction
Grigorescu, V. I., Zhang, Y., Kissin, D. M., Sauber‐Schatz, E. K., Sunderam, M., Kirby, R. S., Diop, H., McKane, P., & Jamieson, D. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.030 · Cited by 28
Polycystic Ovary Syndrome in Adolescence
Baumann, E. E., & Rosenfield, R. L. (2002) · The Endocrinologist · doi:10.1097/00019616-200207000-00011 · Cited by 28
Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals’ Model: In Vitro and In Vivo Studies
Hussain, L., Aamir, N., Hussain, M., Asif, M., Chauhdary, Z., Manzoor, F., Siddique, R., & Riaz, M. S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5143653 · Cited by 26
Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS
Aye, M. M., Butler, A. E., Kilpatrick, E. S., Kirk, R., Vince, R. V., Rigby, A. S., Sandeman, D. D., & Atkin, S. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00592 · Cited by 25
Insulin Resistant States and Insulin Signaling
Vollenweider, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.173 · Cited by 26
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 25
Serum X-box-binding protein 1 levels in PCOS patients
Bahçeci, E., Kaya, C., Karakaş, S., Yıldız, Ş., Hoşgören, M., & Ekin, M. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1942449 · Cited by 24
Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive‐aged women with polycystic ovary syndrome: A systematic review and meta‐analysis of 45 observational studies
Kazemi, M., Pierson, R. A., Parry, S. A., Kaviani, M., & Chilibeck, P. D. (2021) · Obesity Reviews · doi:10.1111/obr.13255 · Cited by 24
Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin
Hansda, S. R., & Haldar, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119755 · Cited by 24
Association of Fibrillin‐3 and Transcription Factor‐7‐Like 2 Gene Variants With Metabolic Phenotypes in PCOS
Yalamanchi, S. K., Sam, S., Cardenas, M. O., Holaday, L. W., Urbanek, M., & Dunaif, A. E. (2012) · Obesity · doi:10.1038/oby.2011.400 · Cited by 23
Self-citation
Risk of Atherosclerosis in Women with Polycystic Ovary Syndrome: A Study from South India
Sundararaman, P. G., Manomani, R., Sridhar, G. R., Sridhar, V., Sundaravalli, A., & Umachander, M. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/1540419031361435 · Cited by 23
Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug
Peng, K., Horng, L., Sung, H., Huang, H., & Wu, R.-T. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.009 · Cited by 23
Progressive Resistance Training in Polycystic Ovary Syndrome: Can Pumping Iron Improve Clinical Outcomes?
Cheema, B. S., Vizza, L., & Swaraj, S. (2014) · Sports Medicine · doi:10.1007/s40279-014-0206-6 · Cited by 25
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?
CHRISTOPOULOS, P. F., Mastorakos, G. P., Gazouli, M., Deligeoroglou, E., Katsikis, I., Diamanti‐Kandarakis, E., Panidis, D., & Creatsas, G. C. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003649823 · Cited by 23
Self-citation
High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome
Kim, J. W., Han, J. E., Kim, Y. S., Won, H. J., Yoon, T. K., & Lee, W. S. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.613967 · Cited by 23
Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial
Stener‐Victorin, E., Zhang, H., Li, R., Fridén, C., Li, D., Wang, W., Wang, H., Chang, C., Shi, L., Huo, Z., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024733 · Cited by 23
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Ho, R. C., Davy, K. P., Hickey, M. S., Summers, S. A., & Melby, C. L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2002 · Cited by 23
Dietary Carbohydrate Intake Does Not Impact Insulin Resistance or Androgens in Healthy, Eumenorrheic Women
Sjaarda, L. A., Schisterman, E. F., Schliep, K. C., Plowden, T. C., Zarek, S. M., Yeung, E. H., Wactawski‐Wende, J., & Mumford, S. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1957 · Cited by 28
Lean mass and insulin resistance in women with polycystic ovary syndrome
Comerford, K. B., Almario, R. U., Kim, K., & Karakas, S. E. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.004 · Cited by 22
Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome
Zhai, J., Li, S., Hu, M., Di, F., Liu, J., & Du, Y. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00592-1 · Cited by 21
Insights into Vitamin E with Combined Oral Contraceptive on INSR Gene in PCOS by Integrating In Silico and In Vivo Approaches
Begum, R. F., & Mohan, S. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04710-8 · Cited by 21
Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome
Espinós, J. J., Corcoy, R., & Calaf, J. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802585597 · Cited by 21
Transforming Growth Factor Beta 1 Alters Glucose Uptake but Not Insulin Signalling in Human Primary Myotubes From Women With and Without Polycystic Ovary Syndrome
McIlvenna, L. C., Patten, R. K., McAinch, A. J., Rodgers, R. J., Stepto, N. K., & Moreno‐Asso, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732338 · Cited by 19
The polycystic ovary syndrome: the first 150 years of study
Adashi, E. Y., Cibula, D., Peterson, M., & Azziz, R. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.12.002 · Cited by 27
Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial
Patel, S. M., Iqbal, N., Kaul, S., Ratcliffe, S. J., Rickels, M. R., Reilly, M. P., Scattergood, T. M., Basu, A., Fuller, C. S., & Cappola, A. R. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.064 · Cited by 20
Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
Connolly, A., Leblanc, S., & Baillargeon, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4315413 · Cited by 19
Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue
Dantas, W. S., Gualano, B., Rocha, M. P., Barcellos, C. R. G., Yance, V. D. R. V., & Marcondes, J. A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/178364 · Cited by 22
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 20
The association between dietary antioxidants, oxidative stress markers, abdominal obesity and poly-cystic ovary syndrome: A case control study
Shahrokhi, S. A., & Naeini, A. A. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1603215 · Cited by 19
Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome
Garruti, G., Palo, R. D., Rotelli, M. T., Nocera, S., Totaro, I., Nardelli, C., Panzarino, M., Vacca, M., Selvaggi, L. E., & Giorgino, F. (2014) · BioMed Research International · doi:10.1155/2014/980429 · Cited by 19
How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study
Zheng, Y., Stener‐Victorin, E., Ng, E. H. Y., Li, J., Wu, X., & Ma, H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007757 · Cited by 19
Self-citation
Insulin resistance and polycystic ovary syndrome
Ehrmann, D. A. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0061-y · Cited by 19
Therapeutic effects of organic zinc on reproductive hormones, insulin resistance and mTOR expression, as a novel component, in a rat model of Polycystic ovary syndrome.
Torshizi, F. F., Chamani, M., Khodaei, H. R., Sadeghi, A. A., Hejazi, S. H., & Heravi, R. M. (2020) · PubMed Central · doi:10.22038/ijbms.2019.36004.8586 · Cited by 21
Targets to treat androgen excess in polycystic ovary syndrome
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 18
The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS
Xirofotos, D., Trakakis, E., Peppa, Μ., Chrelias, C., Panagopoulos, P., Christodoulaki, C., Sioutis, D., & Kassanos, D. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1101440 · Cited by 18
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
Elkind-Hirsch, K. E. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605030-00005 · Cited by 18
The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis
Young, H. E., & Ward, W. E. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00310-7 · Cited by 17
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Third Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2006) · Diabetes Care · doi:10.2337/dc06-zb09 · Cited by 16
The effect of short-term nutritional supplementation of ewes with lupin grain ( Lupinus luteus ) on folliculogenesis, the concentrations of hormones and glucose in plasma and follicular fluid and the follicular levels of P450 aromatase and IRS-1, -2 and -4
Somchit-Assavacheep, A., Campbell, B. K., Khalid, M., Kendall, N. R., & Scaramuzzi, R. J. (2013) · Reproduction · doi:10.1530/rep-12-0135 · Cited by 16
Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome
Tepavčević, S., Milutinović, D. V., Μacut, D., Žakula, Z., Nikolič, M., Antić, I. B., Romić, S., Bjekić-Macut, J., Matić, G. M., & Korićanac, G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.006 · Cited by 15
The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome
Trakakis, E., Basios, G., Peppa, Μ., Simeonidis, G., Labos, G., Creatsa, M. G., Misailidou, M., Boutati, E. I., Vaggopoulos, V., Παναγόπουλος, Π., et al. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.683058 · Cited by 15
Polycystic ovary syndrome
Kovanci, E., & Buster, J. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.068 · Cited by 16
Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?
Siassakos, D. M., & Wardle, P. G. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01418.x · Cited by 15
The polycystic ovary syndrome: what does insulin resistance have to do with it?
Ben‐Shlomo, I. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62053-6 · Cited by 15
Neonatal androgenization-induced early endocrine–metabolic and ovary misprogramming in the female rat
Ongaro, L., Salvetti, N. R., Giovambattista, A., Spinedi, E., & Ortega, H. H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.008 · Cited by 14
Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome
Rissanen, A., Koskela-Koivisto, T., Hägglund, H., Koponen, A. S., Aho, J. M., Pöyhönen‐Alho, M., Tiitinen, A. E., Tikkanen, H. O., & Peltonen, J. E. (2016) · Physiological Reports · doi:10.14814/phy2.12719 · Cited by 14

Authors: Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E.
Affiliations: Brigham and Women's Hospital (US)
Section of Diabetes and Metabolism, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
ORCID: Dunaif, Andrea
Wu, Xinqi
Lee, Anna
Venue: American Journal of Physiology-Endocrinology and Metabolism
Publisher: American Physiological Society
Published: 2001-08-01
Volume: 281
Issue: 2
Pages: E392-E399
ISSN: 0193-1849 (ISSN-L)
1522-1555
DOI: 10.1152/ajpendo.2001.281.2.e392
OpenAlex: W1888335775
Cited by: 337
References: 41
Citations by year: 2026: 7 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 12 · 2021: 16 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 9 · 2016: 8 · 2015: 20 · 2014: 19 · 2013: 13 · 2012: 15
FWCI: 11.14
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor signaling, IRS-1, insulin receptor substrate 2, phosphatidylinositol 3-kinase, hyperinsulinemic-euglycemic clamp
MeSH terms: Adult, Biopsy, Blood Glucose, Chromatography, Thin Layer, Female, Glucose, Humans, Insulin, Insulin Resistance, Phosphoproteins, Polycystic Ovary Syndrome, Receptor, Insulin, RNA, Messenger, Glucose Clamp Technique, Signal Transduction, Body Mass Index, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Reverse Transcriptase Polymerase Chain Reaction, Intracellular Signaling Peptides and Proteins, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks